Atria Investments »

Agios Pharmaceuticals shares owned by Atria Investments

Quarter-by-quarter ownership of Agios Pharmaceuticals (AGIO) shares owned by Atria Investments from 13F filings

Historical chart of Atria Investments investment in Agios Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Agios Pharmaceuticals held by Atria Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Agios Pharmaceuticals by Atria Investments

Quarter filed Position value Share count Share price at filing
2024-09-30 $472k 11k 44.43
2024-06-30 $311k 7.2k 43.12

More positions owned by Atria Investments

Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Unified Ser Tr Oneascent Core P (OACP)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Apple (AAPL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Unified Ser Tr Oneascent Intl (OAIM)
Vanguard Index Fds Value Etf (VTV)
Vanguard Index Fds Growth Etf (VUG)
Meta Platforms Cl A (META)
Ishares Tr Core Total Usd (IUSB)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Unified Ser Tr Oneascent Large (OALC)

View all positions for Atria Investments

Top funds holding Agios Pharmaceuticals

BlackRock
Bellevue Group
T. Rowe Price Associates
Erste Asset Management GmbH
Jpmorgan Chase & Co
Dimensional Fund Advisors
Geode Capital Management
Marshall Wace
BVF
Frazier Life Sciences Management
Bnp Paribas Investment Partners
Arrowpoint Asset Management
Fisher Investments
Vestal Point Capital
Deutsche Bank Aktiengesellschaft

View all funds holding Agios Pharmaceuticals